Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Journal of Clinical Oncology, Vol 22, No 16 (August 15), 2004: pp. 3284-3292
© 2004 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2004.10.012

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Glehen, O.
Right arrow Articles by Rat, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Glehen, O.
Right arrow Articles by Rat, P.

Cytoreductive Surgery Combined With Perioperative Intraperitoneal Chemotherapy for the Management of Peritoneal Carcinomatosis From Colorectal Cancer: A Multi-Institutional Study

O. Glehen, F. Kwiatkowski, P.H. Sugarbaker, D. Elias, E.A. Levine, M. De Simone, R. Barone, Y. Yonemura, F. Cavaliere, F. Quenet, M. Gutman, A.A.K. Tentes, G. Lorimier, J.L. Bernard, J.M. Bereder, J. Porcheron, A. Gomez-Portilla, P. Shen, M. Deraco, P. Rat

From the Centre Hospitalo-Universitaire Lyon Sud, Pierre Bénite; Equipe Accueil 3738, Université Claude Bernard Lyon 1, Oullins; Centre Jean Perrin, Clermont-Ferrand; Institut Gustave Roussy, Villejuif; Centre Val d’Aurelle, Montpellier; Centre Paul Papin, Angers; Centre Hospitalo-Universitaire l’Archet 2, Nice; Centre Hospitalier de Bellevue, Saint-Etienne; Centre Hospitalo-Universitaire, Dijon, France; Shizuoka Cancer Centre, Shizuoka, Japan; Tel Aviv Medical Center, Tel Aviv, Israel; Didimotichon General Hospital, Didimotichon, Greece; San Giuseppe Hospital, Empoli, Florence; Regina Elena National Cancer Institute, Roma; Istituto Nazional Tumori, Milano; Hospital Santiago Apostol, Vitoria, Spain; Washington Hospital Center, Washington, DC; Wake Forest University, Baptist Medical Center, Department of General Surgery, Winston-Salem, NC; and SharpHealthCare, San Diego, CA

Address reprint requests to Francois N. Gilly, MD, PhD, Surgical Department, Centre Hospitalo Universitaire Lyon Sud, 69495 Pierre Bénite cedex, France; e-mail: francogi{at}lyon-sud.univ-lyon1.fr

PURPOSE: The three principal studies dedicated to the natural history of peritoneal carcinomatosis (PC) from colorectal cancer consistently showed median survival ranging between 6 and 8 months. New approaches combining cytoreductive surgery and perioperative intraperitoneal chemotherapy suggest improved survival.

PATIENTS AND METHODS: A retrospective multicenter study was performed to evaluate the international experience with this combined treatment and to identify the principal prognostic indicators. All patients had cytoreductive surgery and perioperative intraperitoneal chemotherapy (intraperitoneal chemohyperthermia and/or immediate postoperative intraperitoneal chemotherapy). PC from appendiceal origin was excluded.

RESULTS: The study included 506 patients from 28 institutions operated between May 1987 and December 2002. Their median age was 51 years. The median follow-up was 53 months. The morbidity and mortality rates were 22.9% and 4%, respectively. The overall median survival was 19.2 months. Patients in whom cytoreductive surgery was complete had a median survival of 32.4 months, compared with 8.4 months for patients in whom complete cytoreductive surgery was not possible (P < .001). Positive independent prognostic indicators by multivariate analysis were complete cytoreduction, treatment by a second procedure, limited extent of PC, age less than 65 years, and use of adjuvant chemotherapy. The use of neoadjuvant chemotherapy, lymph node involvement, presence of liver metastasis, and poor histologic differentiation were negative independent prognostic indicators.

CONCLUSION: The therapeutic approach combining cytoreductive surgery with perioperative intraperitoneal chemotherapy achieved long-term survival in a selected group of patients with PC from colorectal origin with acceptable morbidity and mortality. The complete cytoreductive surgery was the most important prognostic indicator.

Presented in part at the American Society of Clinical Oncology Symposium (Merit Award), San Francisco, CA, January 2004.

Authors’ disclosures of potential conflicts of interest are found at the end of this article.




This article has been cited by other articles:


Home page
Ann. Surg. Oncol.Home page
V. J. Verwaal, S. Bruin, H. Boot, G. van Slooten, and H. van Tinteren
8-Year Follow-up of Randomized Trial: Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Patients with Peritoneal Carcinomatosis of Colorectal Cancer
Ann. Surg. Oncol., September 1, 2008; 15(9): 2426 - 2432.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
N. J. Gusani, S. W. Cho, C. Colovos, S. Seo, J. Franko, S. D. Richard, R. P. Edwards, C. K. Brown, M. P. Holtzman, H. J. Zeh, et al.
Aggressive Surgical Management of Peritoneal Carcinomatosis With Low Mortality in a High-Volume Tertiary Cancer Center
Ann. Surg. Oncol., March 1, 2008; 15(3): 754 - 763.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
R. N. Low, R. M. Barone, J. M. Gurney, and W. D. Muller
Mucinous Appendiceal Neoplasms: Preoperative MR Staging and Classification Compared with Surgical and Histopathologic Findings
Am. J. Roentgenol., March 1, 2008; 190(3): 656 - 665.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
L. Benoit, N. Cheynel, P. Ortega-Deballon, G. Di Giacomo, B. Chauffert, and P. Rat
Closed Hyperthermic Intraperitoneal Chemotherapy with Open Abdomen: a Novel Technique to Reduce Exposure of the Surgical Team to Chemotherapy Drugs
Ann. Surg. Oncol., February 1, 2008; 15(2): 542 - 546.
[Abstract] [Full Text] [PDF]


Home page
Am Soc Clin Oncol Ed BookHome page
E. A. Levine, B. M. Ronnett, P. F. Mansfield, and C. Eng
Overview of Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy for Peritoneal Dissemination of Appendiceal and Colorectal Neoplasms
ASCO Educational Book, January 1, 2008; 2008(1): 153 - 159.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
T. M. Pawlik, R. D. Schulick, and M. A. Choti
Expanding Criteria for Resectability of Colorectal Liver Metastases
Oncologist, January 1, 2008; 13(1): 51 - 64.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
S. Kusamura, D. Baratti, A. Antonucci, R. Younan, B. Laterza, G. D. Oliva, C. Gavazzi, and M. Deraco
Incidence of Postoperative Pancreatic Fistula and Hyperamylasemia after Cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy
Ann. Surg. Oncol., December 1, 2007; 14(12): 3443 - 3452.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
S. Varghese, M. Burness, H. Xu, T. Beresnev, J. Pingpank, and H. R. Alexander
Site-Specific Gene Expression Profiles and Novel Molecular Prognostic Factors in Patients with Lower Gastrointestinal Adenocarcinoma Diffusely Metastatic to Liver or Peritoneum
Ann. Surg. Oncol., December 1, 2007; 14(12): 3460 - 3471.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
F. Aarts, T. Hendriks, O. C. Boerman, M. J. Koppe, W. J. G. Oyen, and R. P. Bleichrodt
A Comparison Between Radioimmunotherapy and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Peritoneal Carcinomatosis of Colonic Origin in Rats
Ann. Surg. Oncol., November 1, 2007; 14(11): 3274 - 3282.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
H. Kagaya, J. Kitayama, A. Hidemura, S. Kaisaki, H. Ishigami, J. Takei, T. Kanazawa, and H. Nagawa
Metastatic Esophageal Tumor from Cecal Carcinoma
Jpn. J. Clin. Oncol., September 4, 2007; (2007) hym078v1.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
S. Kusamura, D. Baratti, R. Younan, B. Laterza, G. D. Oliva, P. Costanzo, M. Favaro, C. Gavazzi, F. Grosso, and M. Deraco
Impact of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy on Systemic Toxicity
Ann. Surg. Oncol., September 1, 2007; 14(9): 2550 - 2558.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
L. Bijelic, T. D. Yan, and P. H. Sugarbaker
Failure Analysis of Recurrent Disease Following Complete Cytoreduction and Perioperative Intraperitoneal Chemotherapy in Patients with Peritoneal Carcinomatosis from Colorectal Cancer
Ann. Surg. Oncol., August 1, 2007; 14(8): 2281 - 2288.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
S. J. Lim, J. N. Cormier, B. W. Feig, P. F. Mansfield, R. S. Benjamin, J. R. Griffin, J. L. Chase, P. W. T. Pisters, R. E. Pollock, and K. K. Hunt
Toxicity and Outcomes Associated with Surgical Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Patients with Sarcomatosis
Ann. Surg. Oncol., August 1, 2007; 14(8): 2309 - 2318.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
T. D. Yan, J. Sim, and D. L. Morris
Selection of Patients with Colorectal Peritoneal Carcinomatosis for Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy
Ann. Surg. Oncol., June 1, 2007; 14(6): 1807 - 1817.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
D. Elias, D. Goere, F. Blot, V. Billard, M. Pocard, N. Kohneh-Shahri, and B. Raynard
Optimization of Hyperthermic Intraperitoneal Chemotherapy With Oxaliplatin Plus Irinotecan at 43{degrees}C After Compete Cytoreductive Surgery: Mortality and Morbidity in 106 Consecutive Patients
Ann. Surg. Oncol., June 1, 2007; 14(6): 1818 - 1824.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
T. Yan, L Welch, D Black, and P. Sugarbaker
A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma
Ann. Onc., May 1, 2007; 18(5): 827 - 834.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
D. Elias, E. Benizri, D. DiPietrantonio, P. Menegon, D. Malka, and B. Raynard
Comparison of Two Kinds of Intraperitoneal Chemotherapy Following Complete Cytoreductive Surgery of Colorectal Peritoneal Carcinomatosis
Ann. Surg. Oncol., February 1, 2007; 14(2): 509 - 514.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
J. Esquivel, R. Sticca, P. Sugarbaker, E. Levine, T. D. Yan, R. Alexander, D. Baratti, D. Bartlett, R. Barone, P. Barrios, et al.
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Management of Peritoneal Surface Malignancies of Colonic Origin: A Consensus Statement
Ann. Surg. Oncol., January 1, 2007; 14(1): 128 - 133.
[Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
T. M. Tuttle, Y. Zhang, E. Greeno, and A. Knutsen
Toxicity and Quality of Life after Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy
Ann. Surg. Oncol., December 1, 2006; 13(12): 1627 - 1632.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
M. Links
Analogies between reading of medical and religious texts
BMJ, November 18, 2006; 333(7577): 1068 - 1070.
[Full Text] [PDF]


Home page
JCOHome page
T. D. Yan, D. Black, R. Savady, and P. H. Sugarbaker
Systematic Review on the Efficacy of Cytoreductive Surgery Combined With Perioperative Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis From Colorectal Carcinoma
J. Clin. Oncol., August 20, 2006; 24(24): 4011 - 4019.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
C. Brigand, O. Monneuse, F. Mohamed, A. C. Sayag-Beaujard, S. Isaac, F. N. Gilly, and O. Glehen
Peritoneal Mesothelioma Treated by Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy: Results of a Prospective Study
Ann. Surg. Oncol., March 1, 2006; 13(3): 405 - 412.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
P. H. Sugarbaker
Decreasing the Risk of a Treatment Expands Its Indications
Ann. Surg. Oncol., November 1, 2005; 12(11): 868 - 870.
[Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
D. Elias, G. Liberale, D. Vernerey, M. Pocard, M. Ducreux, V. Boige, D. Malka, J.-P. Pignon, and P. Lasser
Hepatic and Extrahepatic Colorectal Metastases: When Resectable, Their Localization Does Not Matter, But Their Total Number Has a Prognostic Effect
Ann. Surg. Oncol., November 1, 2005; 12(11): 900 - 909.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
J. Esquivel
Multidisciplinary Sequential Therapy for the Treatment of Peritoneal Surface Malignancies of Colorectal Origin: A Plea for Cooperation Between Medical and Surgical Oncologists
Ann. Surg. Oncol., November 1, 2005; 12(11): 950 - 951.
[Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
J. H. Stewart IV, P. Shen, and E. A. Levine
Intraperitoneal Hyperthermic Chemotherapy for Peritoneal Surface Malignancy: Current Status and Future Directions
Ann. Surg. Oncol., October 1, 2005; 12(10): 765 - 777.
[Abstract] [Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2004 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online